Search
Summit Therapeutics Inc
SMMTAdd to Watchlist
13.105USD
-0.555-4.06%
Close 07-27 16:00（ET）Quotes delayed by 15 min
10.39BMarket Cap
LossP/E TTM
Summit Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-27The current valuation score of Summit Therapeutics Inc is 8.67, ranking 99 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.18, which is -451.59% below the recent high of 28.75 and -3591.33% above the recent low of -301.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.